Clinical trial
Phase III Study of ASP2151 in Herpes Simplex Patients - A Double-blind, Placebo-controlled Study -
NCT01959295 is registered in ClinicalTrials.gov with Maruho Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study of ASP2151 in Herpes Simplex Patients - A Double-blind, Placebo-controlled Study -
- Lead sponsor
- Maruho Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- April 27, 2015
- Enrollment
- 468 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.